Unlimited Transportation Passes for Unstable Housed People Living With HIV Trial

NCT ID: NCT06483152

Last Updated: 2024-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

146 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-31

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this trial is to learn if providing an unlimited transit pass will improve the health of people living with HIV that are experiencing unstable housing.

The main questions it aims to answer are:

1. Do participants who are provided the transit pass manage their HIV better?
2. Do participants who are provided the transit pass use other social services more that could improve their health and quality of life?

Researchers will compare the group that is provided with the transit pass to a control group that is not provided with the pass.

Participants will fill out a baseline survey and a follow-up survey after 6 months. Researchers will also look at participant's HIV lab tests to see how well their HIV is being managed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

People living with HIV who are homeless or unstably housed often face significant barriers to accessing essential health services, including regular medical appointments critical for managing their condition. The current standard of care provides these individuals with limited transportation support - specifically, two $10 bus cards per month - which are quickly expended and often insufficient to meet their basic needs.

The proposed trial aims to address this gap by assessing whether providing unlimited transit passes can enhance health outcomes compared to the current standard. The intervention hypothesizes that removing transportation barriers will increase attendance at medical appointments and utilization of supportive services at The Aliveness Project, a community center offering meals and social services to people living with HIV. By enabling consistent access to public transit, the intervention targets behavioral changes - specifically, the ability of participants to reliably attend health care appointments - and fosters greater engagement with community support resources.

The clinical outcomes of interest in this trial are increased rates of viral suppression, which is a direct indicator of effective HIV management, improved attendance at healthcare appointments, and increased engagement with supportive services at The Aliveness Project. These outcomes not only measure the efficacy of the intervention in improving health management among unstably housed individuals living with HIV but also provide insights into the broader implications of transportation accessibility on public health. By alleviating a fundamental barrier to care, the intervention aims to demonstrate a superior approach to supporting this vulnerable population in achieving and maintaining viral suppression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

transportation transit pass undetectable HIV unstable housing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

The intervention group will be provided a transit pass for the Minneapolis Metro transit system that will be paid for by the study for 6 months.

Group Type EXPERIMENTAL

Metro Transit Pass

Intervention Type OTHER

A transit pass that enables riders to use the Minneapolis Metro Transit system that will paid for by the study for 6 months

Control

The control group will receive the current standard of care, in which people are eligible to receive up to two $10 bus cards from their case manager per month.

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

The current standard of care for Ryan White eligible clients is to receive two $10 bus cards a month from a case manager

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Metro Transit Pass

A transit pass that enables riders to use the Minneapolis Metro Transit system that will paid for by the study for 6 months

Intervention Type OTHER

Standard of Care

The current standard of care for Ryan White eligible clients is to receive two $10 bus cards a month from a case manager

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Member of The Aliveness Project
* • Live, reside, or stay regularly outside within the 13 county area surrounding the Twin Cities known in the Ryan White system as the MINNEAPOLIS ST. PAUL TRANSITIONAL GRANT AREA or TGA. This is the same general area as the area where Metro Transit serves, which makes it a convenient reference.
* • Be a person experiencing unstable housing or homelessness

* Because the residence and housing status of this group rapidly shifts -hence unstable--the following definition of unstable housing was developed in collaboration with Aliveness\'s housing stabilization team, which serves this population:

Meet one of three criteria:

* Currently reports living in one of the following housing conditions:

* Outside, in a car, or another space unfit for human habitation
* A homeless shelter
* Temporary housing with a friend or relative (couch hopping) to which they do not have long-term stable access.
* Currently lives in a temporary group home or substance abuse treatment program, but lived in one of the above housing conditions prior to entry within the last three months.
* Is listed in the CAREWare database system as being homeless or having temporary or unstable housing.

Exclusion Criteria

* • Inability to provide informed consent

* Inability to communicate in English
* Not an Aliveness member in good standing: Some Aliveness members have been banned from the space because of behavioral or safety concerns. Aliveness\'s Member Advisory Committee reviews all such expulsions on a case-by-case basis.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Aliveness Project

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jay Orne, PhD

Research Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jay Orne, PhD

Role: PRINCIPAL_INVESTIGATOR

The Aliveness Project

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Aliveness Project

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jay Orne, PhD

Role: CONTACT

Phone: 612-824-5433

Email: [email protected]

Executive Director

Role: CONTACT

Phone: 612-824-5433

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jay Orne, PhD

Role: primary

Executive Director

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IN-US-985-7161

Identifier Type: -

Identifier Source: org_study_id